Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Gen Digital Inc., formerly known for its antivirus software, is undergoing a significant transformation as it expands into ...

Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

Recent studies have focused on the design, production, and application of these antibodies, revealing their potential to revolutionize therapeutic strategies in immunology. Recent research has ...

Direct comparative efficacy studies are few, and also may have design issues, which make their interpretation difficult. The most serious safety issues for monoclonal antibodies include the risk ...

Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more ...